TY - JOUR
T1 - Actinic Keratosis Clinical Practice Guidelines
T2 - An Appraisal of Quality
AU - Kirby, Joslyn S.
AU - Scharnitz, Thomas
AU - Seiverling, Elizabeth V.
AU - Ahrns, Hadjh
AU - Ferguson, Sara
N1 - Publisher Copyright:
© 2015 Joslyn S. Kirby et al.
PY - 2015
Y1 - 2015
N2 - Actinic keratosis (AK) is a common precancerous skin lesion and many AK management guidelines exist, but there has been limited investigation into the quality of these documents. The objective of this study was to assess the strengths and weaknesses of guidelines that address AK management. A systematic search for guidelines with recommendations for AK was performed. The Appraisal of Guidelines for Research and Evaluation (AGREE II) was used to appraise the quality of guidelines. Multiple raters independently reviewed each of the guidelines and applied the AGREE II tool and scores were calculated. Overall, 2,307 citations were identified and 7 fulfilled the study criteria. The Cancer Council of Australia/Australian Cancer Network guideline had the highest mean scores and was the only guideline to include a systematic review, include an evidence rating for recommendations, and report conflicts of interest and funding sources. High-quality, effective guidelines are evidence-based with recommendations that are concise and organized, so practical application is facilitated. Features such as concise tables, pictorial diagrams, and explicit links to evidence are helpful. However, the rigor and validity of some guidelines were weak. So, it is important for providers to be aware of the features that contribute to a high-quality, practical document.
AB - Actinic keratosis (AK) is a common precancerous skin lesion and many AK management guidelines exist, but there has been limited investigation into the quality of these documents. The objective of this study was to assess the strengths and weaknesses of guidelines that address AK management. A systematic search for guidelines with recommendations for AK was performed. The Appraisal of Guidelines for Research and Evaluation (AGREE II) was used to appraise the quality of guidelines. Multiple raters independently reviewed each of the guidelines and applied the AGREE II tool and scores were calculated. Overall, 2,307 citations were identified and 7 fulfilled the study criteria. The Cancer Council of Australia/Australian Cancer Network guideline had the highest mean scores and was the only guideline to include a systematic review, include an evidence rating for recommendations, and report conflicts of interest and funding sources. High-quality, effective guidelines are evidence-based with recommendations that are concise and organized, so practical application is facilitated. Features such as concise tables, pictorial diagrams, and explicit links to evidence are helpful. However, the rigor and validity of some guidelines were weak. So, it is important for providers to be aware of the features that contribute to a high-quality, practical document.
UR - http://www.scopus.com/inward/record.url?scp=84942904875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942904875&partnerID=8YFLogxK
U2 - 10.1155/2015/456071
DO - 10.1155/2015/456071
M3 - Review article
C2 - 26451140
AN - SCOPUS:84942904875
SN - 1687-6105
VL - 2015
JO - Dermatology Research and Practice
JF - Dermatology Research and Practice
M1 - 456071
ER -